History
# Registration date Revision Id
2 2026-10-06, 1405/07/14 398732
1 2024-06-08, 1403/03/19 304315
Changes made to previous revision
  • Help:

    Red color represents old content. It may be empty showing addition in the new version.
    Green color represents new content. It may be empty showing deletion in the new version.

    Inline Side by side
    Added new contents, deleted old contents, contents that are not changed.
    New table contents New table contents
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    Added new contents, contents that are not changed.
    Deleted old contents, contents that are not changed.
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    New table contents New table contents
    Unchanged contents Unchanged contents
  • General information

    Not used
    Used
    3
    2
    empty
    This update is being made to clarify and complete the registered information regarding the conduct of the study and to improve the consistency of the trial record with the study protocol and the actual procedures used during the study. These updates do not change the overall nature of the intervention or the main objectives of the study.
    empty
    این به‌روزرسانی با هدف شفاف‌سازی و تکمیل اطلاعات ثبت‌شده در خصوص نحوه اجرای مطالعه و افزایش تطابق رکورد کارآزمایی با پروتکل مطالعه و روش اجرای واقعی آن انجام شده است.. این به‌روزرسانی با هدف افزایش شفافیت، قابلیت بازتولید و تطابق اطلاعات ثبت‌شده با مطالعه انجام شده است و ماهیت کلی مداخله و اهداف اصلی مطالعه را تغییر نمی‌دهد.
    In control group 1; headphones are placed on the patient's ear. But the headphones have no function, and the patient is able to hear the surrounding sounds naturally through the holes made on the ear part of the headphones. In control group 2; healthy headphones but without sound function are placed on the patient's ear so that he cannot hear the surrounding sounds. In intervention groups; healthy headphones with a specific frequency are used. Due to the appearance of identical interventions and the patient's lack of information about the grouping and type of stimulation intervention frequency, the patients were blinded to the intervention. Anesthesia and administration of patients during anesthesia is done by the project colleague. Audio frequency was applied through headphones and audio frequency settings were done through Bluetooth headphones. The other colleague who registers the variables does not know the way of grouping and the type of frequency received by the patients.
    In Control Group 1, headphones were placed over the patient’s ears; however, the headphones had no audio function and contained openings over the ear area, allowing patients to hear environmental sounds naturally. In Control Group 2, intact but inactive headphones were placed over the patient’s ears, preventing the patients from hearing environmental sounds. In the intervention groups, intact headphones were used to deliver auditory stimulation at the specified frequencies. Because the headphones were visually identical and patients were unaware of their group allocation and the frequency of the auditory stimulation, patients were blinded to both group assignment and intervention frequency. An investigator involved in the project was responsible for administering anesthesia and managing the patients throughout the anesthetic period and was blinded to group allocation and stimulation frequency. Auditory stimulation was delivered through the headphones, with the stimulation frequency configured via the headphones’ Bluetooth connection. Another researcher responsible for recording the study variables was unaware of the patients’ group allocation and the frequency of auditory stimulation received and was blinded to both. Statistical analyses were performed after completion of data collection.
    در گروه کنترل 1؛ هدفون بر روی گوش بیمار قرار داده می شود. ولی هدفون فاقد عملکرد می باشد و همچنین از طریق سوراخ های که بر روی قسمت روی گوش هدفون انجام شده است بیمار قادر به شنیدن صداهای محیطی بصورت طبیعی است. در گروه کنترل 2؛ هدفون سالم ولی فاقد عملکرد صوتی بر روی گوش بیمار قرار داده می شود بطوری که قادر به شنیدن صداهای محیطی نباشد. در گروه های مداخله؛ هدفون سالم با فرکانس مشخص استفاده می شود. با توجه به مداخلات ظاهری یکسان و عدم اطلاع بیمار از گروه بندی و نوع فرکانس مداخله تحریکی بیماران نسبت به مداخله کور بودند. انجام بیهوشی و اداره بیماران در طول بیهوشی توسط همکار پروژه انجام می شود. اعمال فرکانس صوتی از طریق هدفون و تنظیمات فرکانس صوتی از طریق بلوتوث هدفون انجام می شد. همکار دیگر ثبت کننده متغییر ها از نحوه گروه بندی و نوع فرکانس دریافتی بیماران اطلاعی ندارد.
    در گروه کنترل 1، هدفون روی گوش بیمار قرار داده می‌شد، اما هدفون فاقد عملکرد صوتی بود و به‌دلیل وجود سوراخ‌هایی در قسمت روی گوش هدفون، بیمار قادر بود صداهای محیطی را به‌طور طبیعی بشنود. در گروه کنترل 2، هدفون سالم اما فاقد عملکرد صوتی روی گوش بیمار قرار داده می‌شد، به‌گونه‌ای که بیمار قادر به شنیدن صداهای محیطی نبود. در گروه‌های مداخله، از هدفون سالم برای ارائه تحریک صوتی با فرکانس مشخص استفاده می‌شد. با توجه به ظاهر مشابه هدفون‌ها و عدم اطلاع بیماران از تخصیص گروهی و نوع فرکانس تحریک، بیماران نسبت به گروه و نوع مداخله کور بودند. انجام بیهوشی و اداره بیماران در طول دوره بیهوشی توسط همکار پروژه انجام می‌شد و متخصص بیهوشی نسبت به تخصیص گروهی و نوع فرکانس تحریک کور بود. اعمال تحریک صوتی از طریق هدفون و تنظیم فرکانس صوتی از طریق اتصال بلوتوث هدفون انجام می‌شد. پژوهشگر دیگری که مسئول ثبت متغیرهای مطالعه بود، از تخصیص گروهی و نوع فرکانس صوتی دریافتی بیماران اطلاعی نداشت و نسبت به این موارد کور بود. داده‌ها پس از تکمیل جمع‌آوری داده‌ها مورد تحلیل آماری قرار گرفتند.
  • Primary outcomes

    #1
    Heart rate is measured before, immediately and also in 1, 3 and 5 minutes after intubation and extubation.
    It is measured immediately and at 1, 2, 3, 4, and 5 minutes after intubation and extubation.
    ضربان قلب قبل، بلافاصله و همچنین در دقایق 1، 3 و 5 بعد از لوله گذاری و خارج کردن لوله اندازه گیری می شود.
    بلافاصله و همچنین در دقایق 1، 2، 3، 4 و 5 بعد از لوله گذاری و خارج کردن لوله اندازه گیری می شود.
    #2
    Systolic and diastolic blood pressure
    mean arterial pressure
    فشار خون سیستولیک و دیاستولیک
    فشار خون میانگین
    Systolic and diastolic Blood pressure is measured before, immediately and also in 1, 3 and 5 minutes after intubation and extubation.
    It is measured immediately and at 1, 2, 3, 4, and 5 minutes after intubation and extubation.
    فشار خون سیستولیک و دیاستولیک قبل، بلافاصله و همچنین در دقایق 1، 3 و 5 بعد از لوله گذاری و خارج کردن لوله اندازه گیری می شود.
    بلافاصله و همچنین در دقایق 1، 2، 3، 4 و 5 بعد از لوله گذاری و خارج کردن لوله اندازه گیری می شود.
    Systolic and diastolic blood pressure
    using a monitor connected to the patient.
    #3
    Before leaving the recovery department
    Before discharge from the recovery unit and at 1, 3, and 6 hours after surgery.
    قبل از خروج از بخش ریکاوری
    قبل از خروج از بخش ریکاوری و در ساعات 1، 3و 6 بعد از جراحی
    #4
    Using patient-connected monitoring
    using a monitor connected to the patient
    #5
    empty
    Bispectral Index value during general anesthesia
    empty
    مقدار شاخص دوطیفی در طی بیهوشی عمومی
    empty
    Before induction of general anesthesia, after induction of general anesthesia, and at 15, 30, 45, and 60 minutes, as well as after extubation.
    empty
    قبل از القای بیهوشی عمومی، پس از القای بیهوشی عمومی، و در دقایق ۱۵، ۳۰، ۴۵، ۶۰ و بعد از اکستوباسیون
    empty
    Continuous monitoring using a bispectral index monitor with a disposable forehead sensor
    empty
    پایش مداوم با استفاده از دستگاه اندازه‌گیری شاخص دوطیفی و حسگر یک‌بارمصرف پیشانی
  • Intervention groups

    #1
    Control group: patients do not receive any stimulation intervention.
    Control 1 group: perforated wireless headphones are placed over both ears, and patients do not receive any auditory stimulus or stimulation intervention. The perforated headphones allow ambient sounds to remain audible.
    گروه کنترل: بیماران هیچ گونه مداخله تحریکی دریافت نمی کنند.
    گروه کنترل1: گروه کنترل: هدفون بی‌سیم سوراخ‌دار روی هر دو گوش قرار داده می‌شود و بیماران هیچ‌گونه محرک یا مداخله تحریک صوتی دریافت نمی‌کنند. هدفون سوراخ‌دار امکان شنیدن صدای محیط را فراهم می‌کند
    #2
    Control group: passive wireless headphones are placed on each ear so that the intensity of the ambient sound is less than 5 dB, and the patients in this group do not receive any sound stimuli.
    Control 2 group: passive wireless headphones are placed over both ears to reduce the intensity of ambient sound to less than 5 dB, and patients in this group do not receive any sound stimuli.
    گروه کنترل: هدفون بی سیم غیرفعال روی هر دوگوش قرار داده می شود تا شدت دریافت صدای محیط به کمتر از 5 دسی بل برسد و بیماران در این گروه هیچ محرک صوتی دریافت نمی کنند.
    گروه کنترل 2: هدفون بی‌سیم غیرفعال روی هر دو گوش قرار داده می‌شود تا شدت صدای محیط به کمتر از 5 دسی‌بل برسد و بیماران در این گروه هیچ محرک صوتی دریافت نمی‌کنند.

Protocol summary

Study aim
Determining the effects of using sound frequencies on the level of analgesia and hemodynamic disorders during intubation and extubation in patients under general anesthesia.
Design
The current study is a randomized double-blind clinical trial in phase 2 with a control group, which is conducted on 175 patients. The randomization of the samples is done using the order of random letters by computer software.
Settings and conduct
The study is conducted on elective candidates for general anesthesia in Imam Reza Hospital, Kermanshah. In the intervention groups, the application of different sound frequencies during the process of general anesthesia is done by headphones. The patients and the researcher who recorded the data do not know about the grouping and the type of intervention.
Participants/Inclusion and exclusion criteria
Patients who are under general anesthesia.
Intervention groups
In control group 1; patients do not receive any sound stimulation. In control group 2; passive wireless headphones are placed on both ears of the patient so that the ambient sound intensity is less than 5 dB and the patient does not receive any sound stimuli. In the intervention groups: sound stimulation with frequencies of 5, 10, 20, 50 and 100 Hz from the time of entering the operating room until the patient leaves the recovery room through wireless headphones, receives sound stimulation with a sound intensity of 50 dB.
Main outcome variables
Changes in blood pressure; change in heart rate ; pain level; comfort; anxiety

General information

Reason for update
This update is being made to clarify and complete the registered information regarding the conduct of the study and to improve the consistency of the trial record with the study protocol and the actual procedures used during the study. These updates do not change the overall nature of the intervention or the main objectives of the study.
Acronym
IRCT registration information
IRCT registration number: IRCT20240123060780N3
Registration date: 2024-06-08, 1403/03/19
Registration timing: prospective

Last update: 2026-10-08, 1405/07/16
Update count: 1
Registration date
2024-06-08, 1403/03/19
Registrant information
Name
Rasoul Kavyannejad
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 83 3427 4618
Email address
r.kavyannejad@kums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-07-22, 1403/05/01
Expected recruitment end date
2025-07-23, 1404/05/01
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
The effects of using sound frequencies on analgesia level and hemodynamic disorders during intubation and extubation in patients under general anesthesia
Public title
Effects of sound frequencies on analgesia and hemodynamic changes
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Not having a history of underlying diseases such as blood pressure, diabetes, heart and lung diseases Patients with American Society of Anesthesiology (ASA) classification 1 and 2 Airway grade 1 Not receiving premedication the night before and the morning of the operation having full normal hearing (25 dB hearing threshold) Having full consciousness
Exclusion criteria:
History of smoking and addiction Having an ear infection and anatomical abnormalities of the auditory system Non-cooperation of the patient
Age
From 20 years old to 50 years old
Gender
Both
Phase
2
Groups that have been masked
  • Participant
  • Care provider
  • Outcome assessor
Sample size
Target sample size: 175
Randomization (investigator's opinion)
Randomized
Randomization description
Randomization of samples in this study is done by computer software.Due to the 7 groups, a random order of letters A, B, C, D, E, F, G is made in blocks with a random number of 7 letters. Each letter is a symbol of one of the study groups. Then these obtained blocks are placed in sealed envelopes. Before starting the study, one of the researchers opens one of the envelopes and finally the patient is placed in one of the intervention or control groups.
Blinding (investigator's opinion)
Double blinded
Blinding description
In Control Group 1, headphones were placed over the patient’s ears; however, the headphones had no audio function and contained openings over the ear area, allowing patients to hear environmental sounds naturally. In Control Group 2, intact but inactive headphones were placed over the patient’s ears, preventing the patients from hearing environmental sounds. In the intervention groups, intact headphones were used to deliver auditory stimulation at the specified frequencies. Because the headphones were visually identical and patients were unaware of their group allocation and the frequency of the auditory stimulation, patients were blinded to both group assignment and intervention frequency. An investigator involved in the project was responsible for administering anesthesia and managing the patients throughout the anesthetic period and was blinded to group allocation and stimulation frequency. Auditory stimulation was delivered through the headphones, with the stimulation frequency configured via the headphones’ Bluetooth connection. Another researcher responsible for recording the study variables was unaware of the patients’ group allocation and the frequency of auditory stimulation received and was blinded to both. Statistical analyses were performed after completion of data collection.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Kermanshah University of Medical Sciences
Street address
No. 2 Central Building, Kermanshah University of Medical Sciences, Shahid Beheshti Street, Kermanshah, Iran
City
Kermanshah
Province
Kermanshah
Postal code
6715847141
Approval date
2024-01-30, 1402/11/10
Ethics committee reference number
IR.KUMS.REC.1403.102

Health conditions studied

1

Description of health condition studied
Pain
ICD-10 code
G89.1
ICD-10 code description
Acute pain, not elsewhere classified

2

Description of health condition studied
surgical pain
ICD-10 code
G89.18
ICD-10 code description
Other acute postprocedural pain

Primary outcomes

1

Description
Heart rate
Timepoint
It is measured immediately and at 1, 2, 3, 4, and 5 minutes after intubation and extubation.
Method of measurement
Using monitoring connected to the patient

2

Description
mean arterial pressure
Timepoint
It is measured immediately and at 1, 2, 3, 4, and 5 minutes after intubation and extubation.
Method of measurement
using a monitor connected to the patient.

3

Description
Anxiety
Timepoint
It is measured before induction of anesthesia.
Method of measurement
The visual analog scale

4

Description
comfort
Timepoint
It is measured before induction of anesthesia.
Method of measurement
The visual analog scale

5

Description
Pain
Timepoint
Before discharge from the recovery unit and at 1, 3, and 6 hours after surgery.
Method of measurement
The visual analog scale

6

Description
Systolic and diastolic blood pressure
Timepoint
Every 15 minutes during anesthesia and also before leaving the recovery room
Method of measurement
using a monitor connected to the patient

7

Description
Heart rate
Timepoint
Every 15 minutes during anesthesia and also before leaving the recovery room
Method of measurement
Using patient-connected monitoring

8

Description
Bispectral Index value during general anesthesia
Timepoint
Before induction of general anesthesia, after induction of general anesthesia, and at 15, 30, 45, and 60 minutes, as well as after extubation.
Method of measurement
Continuous monitoring using a bispectral index monitor with a disposable forehead sensor

Secondary outcomes

1

Description
The amount of narcotic drugs used for analgesia (morphin) in the recovery department
Timepoint
It is measured in the recovery section.
Method of measurement
In terms of milligrams of the drug injected by anesthesia personnel

Intervention groups

1

Description
Control 1 group: perforated wireless headphones are placed over both ears, and patients do not receive any auditory stimulus or stimulation intervention. The perforated headphones allow ambient sounds to remain audible.
Category
Placebo

2

Description
Control 2 group: passive wireless headphones are placed over both ears to reduce the intensity of ambient sound to less than 5 dB, and patients in this group do not receive any sound stimuli.
Category
Placebo

3

Description
Intervention group: patients receive sound stimulation with a frequency of 5 Hz and sound intensity of 50 dB through wireless headphones.
Category
Treatment - Devices

4

Description
Intervention group: patients receive sound stimulation with a frequency of 10 Hz and sound intensity of 50 dB through wireless headphones.
Category
Treatment - Devices

5

Description
Intervention group: patients receive sound stimulation with a frequency of 20 Hz and sound intensity of 50 dB through wireless headphones.
Category
Treatment - Devices

6

Description
Intervention group: patients receive sound stimulation with a frequency of 50 Hz and sound intensity of 50 dB through wireless headphones.
Category
Treatment - Devices

7

Description
Intervention group: patients receive sound stimulation with a frequency of 100 Hz and sound intensity of 50 dB through wireless headphones.
Category
Treatment - Devices

Recruitment centers

1

Recruitment center
Name of recruitment center
Imam Reza Hospital
Full name of responsible person
said mohamadi
Street address
Imam Reza Hospital, Parastar boulevard, Sorkhalijeh, Kermanshah
City
Kermanshah
Province
Kermanshah
Postal code
6742775333
Phone
+98 83 3427 6300
Email
dr.saidmohamadi@gmail.com

2

Recruitment center
Name of recruitment center
Imam Khomeini Hospital
Full name of responsible person
Said mohamadi
Street address
Imam Khomeini hospital ,Naghlye street, Kermanshah
City
Kermanshah
Province
Kermanshah
Postal code
6718743161
Phone
+98 83 3728 3602
Email
dr.saidmohamadi@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Kermanshah University of Medical Sciences
Full name of responsible person
Cyrus Jalili
Street address
No. 2 Central Building, Kermanshah University of Medical Sciences, Shahid Beheshti Street, Kermanshah, Iran
City
Kermanshah
Province
Kermanshah
Postal code
6714673159
Phone
+98 83 3838 6835
Email
research_it@kums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Kermanshah University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Kermanshah University of Medical Sciences
Full name of responsible person
Said mohamadi
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
School of Medicine, St. University, shahid Shiroudi Boulevard, Kermanshah
City
Kermanshah
Province
Kermanshah
Postal code
6714869914
Phone
+98 83 3427 4618
Fax
Email
dr.saidmohamadi@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Kermanshah University of Medical Sciences
Full name of responsible person
Said mohamadi
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
School of Medicine, St. University, shahid Shiroudi Boulevard, Kermanshah
City
Kermanshah
Province
Kermanshah
Postal code
6714869914
Phone
+98 83 3427 4618
Fax
Email
dr.saidmohamadi@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Kermanshah University of Medical Sciences
Full name of responsible person
Said mohamadi
Position
Assistant professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
School of Medicine, St. University, shahid Shiroudi Boulevard, Kermanshah
City
Kermanshah
Province
Kermanshah
Postal code
6714869914
Phone
+98 83 3427 4618
Fax
Email
dr.saidmohamadi@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
No - There is not a plan to make this available
Statistical Analysis Plan
No - There is not a plan to make this available
Informed Consent Form
No - There is not a plan to make this available
Clinical Study Report
No - There is not a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
No - There is not a plan to make this available
Loading...